60 Degrees Pharmaceuticals, Inc.
Nasdaq · Pharmaceutical Preparations · Washington, DC
SXTPW chart
What traders are saying about $SXTPW
Latest posts60 Degrees Pharmaceuticals, Inc. news
- Harrow (HROW) Q3 Earnings Lag Estimates
Yahoo Finance ·
- Weekly Recap: Interim babesiosis analysis set and warrants raise $526,043
TradingView ·
- 60 Degrees Pharmaceuticals Announces Warrant Inducement Financing Agreement
The Globe and Mail ·
- Form 8K 60 Degrees Pharmaceuticals Inc For: 6 November By Investing.com
Investing.com Nigeria ·
- Ironwood Pharmaceuticals (IRWD) Beats Q3 Earnings Estimates
Yahoo Finance ·
- 60 Degrees Pharmaceuticals (SXTP) Slips 5.35% to $0.96 as Shares Drift Toward Lower Support - VOLD Alert
https://www.siam.in/ ·
- Join 60 Degrees Pharmaceuticals' Live Investor Webinar: Advancing Tafenoquine for Babesiosis While Expanding ARAKODA(R) Commercialization
Yahoo Finance ·
- 60 Degrees Pharmaceuticals Announces Partnership with The University of Southern Mississippi to Evaluate Castanospermine in Nonclinical Models of Alpha-Gal Syndrome
Yahoo Finance ·
- 60 Degrees Pharmaceuticals Announces Clinical Improvement and Negative PCR Results in All Completed Expanded Access Babesiosis Study Patients
Yahoo Finance ·
- 60 Degrees Pharmaceuticals Sets January 2027 Babesiosis Data Readout and Plans FDA Pre-sNDA Meeting
investorshub.advfn.com ·
- 60 Degrees Pharmaceuticals Plans January 2027 Hospitalized Babesiosis Data Readout; Will Seek Pre-sNDA Meeting with FDA
Yahoo Finance ·
- 60 Degrees Pharmaceuticals and Exyn Technologies Interviews to Air Nationally on the RedChip Small Stocks, Big Money(TM) Show on CNBC and Bloomberg TV
Yahoo Finance ·
60 Degrees Pharmaceuticals, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $1.0M | $607,574 | $253,573 | $223,208 |
| Net income | -$7.4M | -$7.9M | -$3.8M | -$6.2M |
| Diluted EPS | $-11.73 | $-74.17 | $-59.18 | $-2.61 |
| Total assets (year end) | $5.4M | $5.8M | $7.8M | $1.3M |
| Cash and equivalents (year end) | $1.5M | $1.7M | $2.1M | – |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About 60 Degrees Pharmaceuticals, Inc.
- Ticker
- SXTPW (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Washington, DC
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1946563
Frequently asked questions
What exchange is 60 Degrees Pharmaceuticals, Inc. listed on?
60 Degrees Pharmaceuticals, Inc. trades on the Nasdaq under the ticker symbol SXTPW.
What industry is 60 Degrees Pharmaceuticals, Inc. in?
60 Degrees Pharmaceuticals, Inc. is classified by the SEC under "Pharmaceutical Preparations".
Where is 60 Degrees Pharmaceuticals, Inc. headquartered?
60 Degrees Pharmaceuticals, Inc.'s business address on file with the SEC is in Washington, DC.
When does 60 Degrees Pharmaceuticals, Inc.'s fiscal year end?
60 Degrees Pharmaceuticals, Inc.'s fiscal year ends on December 31.
How much revenue did 60 Degrees Pharmaceuticals, Inc. report?
60 Degrees Pharmaceuticals, Inc. reported $1.0M in revenue for calendar year 2025, according to its SEC filings.